Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time.
Sign up now!

The 2019 ASGCT Annual Meeting is expected to be the largest in Society
history, eclipsing the mark set by the 2018 meeting just last year. Join more
than 3,500 researchers, clinicians, advocates, and industry leaders in
discovering the latest science and technology surrounding gene and cell
therapy. More info >>

Luina Bio, a leading biopharmaceutical manufacturing company in
Australia, today announced it will develop and produce an innovative
bacterial drug product for Genome & Company to support its clinical
trials programme. The relationship signals Luina Bio’s first foray into
Asia and further establishes its global leadership in the current Good
Manufacturing Practise for microbiome projects.More info >>